Alterity Therapeutics (ATHE) Non-Current Assets (2009 - 2025)

Alterity Therapeutics' Non-Current Assets history runs 16 years deep, the most recent figure standing at $62953.8 for Q4 2025.

• In Q4 2025, Non-Current Assets fell 16.83% year-over-year to $62953.8; the TTM figure through Dec 2025 stood at $62953.8 (down 16.83% YoY), while the FY2025 annual figure was $99378.6, down 32.4% from the prior year.
• Non-Current Assets was $62953.8 for Q4 2025 at Alterity Therapeutics, down from $99378.6 in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $179697.4 in Q2 2023 to a low of $49763.2 in Q4 2021.
• Historically, Non-Current Assets has averaged $106632.1 across 5 years, with a median of $107060.4 in 2022.
• The sharpest annual moves came in 2022 and 2024: Non-Current Assets jumped 130.58% in 2022, then plunged 41.71% in 2024.
• A 5-year view of Non-Current Assets shows it stood at $49763.2 in 2021, then surged by 130.58% to $114742.3 in 2022, then increased by 13.18% to $129861.5 in 2023, then slumped by 41.71% to $75696.1 in 2024, then slipped by 16.83% to $62953.8 in 2025.
• The last three Non-Current Assets figures came in at $62953.8 (Q4 2025), $99378.6 (Q2 2025), and $75696.1 (Q4 2024), per Business Quant data.